JURA Bio Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
10
JURA Bio General Information
Description
Developer of AI foundation models designed to accelerate therapeutic discovery and development. The company integrates machine learning, synthetic biology, and high-throughput experimentation through iterative cycles of design, synthesis, and screening to produce proprietary functional data, enabling biopharmaceutical researchers to discover and develop novel therapeutic candidates across antibodies, peptides, enzymes, T-cell engagers, and other emerging modalities.
Contact Information
Website
www.jurabio.comCorporate Office
- 100 Morrissey Boulevard
- Boston, MA 02125
- United States
Corporate Office
- 100 Morrissey Boulevard
- Boston, MA 02125
- United States
JURA Bio Timeline
JURA Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 5. Accelerator/Incubator | 19-Oct-2023 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 21-Sep-2023 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 29-Mar-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
JURA Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
JURA Bio Patents
JURA Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026060280-A1 | Methods enabling in vitro sampling of biological sequence models and synthesis of biological molecule libraries at petascales | Pending | 12-Sep-2024 | ||
| WO-2023235856-A1 | Apoptosis resistant immune cells with major histocompatibility complex chimeric antigen receptor | Inactive | 03-Jun-2022 | ||
| AU-2018365080-A1 | Major histocompatibility complex-based chimeric receptors and uses thereof for treating autoimmune diseases | Active | 10-Nov-2017 | ||
| AU-2018365080-B2 | Major histocompatibility complex-based chimeric receptors and uses thereof for treating autoimmune diseases | Active | 10-Nov-2017 | ||
| AU-2025252604-A1 | Major histocompatibility complex-based chimeric receptors and uses thereof for treating autoimmune diseases | Pending | 10-Nov-2017 | C07K14/70521 |
JURA Bio Signals
JURA Bio Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Massachusetts Biomedical Initiatives | Accelerator/Incubator | |||
| Fontus Capital | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Massachusetts Life Sciences Center | Government | Minority | ||
| Angel (individual) | Minority |
JURA Bio FAQs
-
When was JURA Bio founded?
JURA Bio was founded in 2017.
-
Where is JURA Bio headquartered?
JURA Bio is headquartered in Boston, MA.
-
What is the size of JURA Bio?
JURA Bio has 13 total employees.
-
What industry is JURA Bio in?
JURA Bio’s primary industry is Drug Discovery.
-
Is JURA Bio a private or public company?
JURA Bio is a Private company.
-
What is JURA Bio’s current revenue?
The current revenue for JURA Bio is .
-
How much funding has JURA Bio raised over time?
JURA Bio has raised $32.6M.
-
Who are JURA Bio’s investors?
Massachusetts Biomedical Initiatives, Fontus Capital, , Massachusetts Life Sciences Center, and are 5 of 10 investors who have invested in JURA Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process